03/04
Headlines

NASDAQ:CYTR

Today’s Stocks : CytRx Corporation (NASDAQ:CYTR), Advanced Micro Devices, (NYSE:AMD), First Community Bancshares, Inc. (NASDAQ:FCBC), Altra Industrial Motion Corp. (NASDAQ:AIMC), Excel (NYSE:EXL)

Chris Lewis03 mins

CytRx Corporation (NASDAQ: CYTR) a biopharmaceutical research and development company specializing in oncology today announced a change in the Company’s presentation time at the at Aegis 2014 Healthcare & Technology Conference. President and CEO Steven A. Kriegsman and Vice President of Business Development David Haen will present on Friday September 12th at 10:45am Pacific Time….

Read More

Trader’s Watch List – Bed Bath (NASDAQ:BBBY) , Walt Disney (NYSE:DIS) , Rexnord (NYSE:RXN) , CytRx (NASDAQ:CYTR) , Eldorado Gold (NYSE:EGO)

Kevin Long03 mins

Analysts at Nomura started coverage on shares of Bed Bath & Beyond (NASDAQ:BBBY) in a research report issued to clients and investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $65.00 price target on the stock. Nomura’s target price would indicate a potential upside of 6.56% from the company’s current price….

Read More

Healthcare Losers: CytRx (NASDAQ:CYTR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), Ventrus Biosciences Inc (NASDAQ:VTUS)

Kristen Barton03 mins

The company on May 28 announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS). CytRx Corporation (NASDAQ:CYTR) stock performance was -5.41% in last session and…

Read More

Top Losers: StemCells (NASDAQ:STEM), CytRx (NASDAQ:CYTR), Neonode (NASDAQ:NEON), Halcon Resources (NYSE:HK), Yamana Gold (NYSE:AUY)

Jayne Crisman03 mins

Research analysts at Maxim Group lifted their price target on shares of Stemcells Inc (NASDAQ:STEM) from $2.50 to $5.00 in a report released on Friday. The firm currently has a “buy” rating on the stock. Maxim Group’s price objective indicates a potential upside of 155.10% from the company’s current price. StemCells Inc (NASDAQ:STEM) stock performance…

Read More

Biotech Volatile Movements: CEL-SCI (NYSEMKT:CVM), NewLink Genetics (NASDAQ:NLNK), Alder Biopharmaceuticals (NASDAQ:ALDR), CytRx (NASDAQ:CYTR), StemCells Inc (NASDAQ:STEM)

Kevin Long03 mins

CEL-SCI Corporation (NYSEMKT:CVM) announced that Geert Kersten Chief Executive Officer will be presenting at the 2014 BIO International Convention on Wednesday June 25th at 2:00 p.m. PDT. Hosted by the Biotechnology Industry Organization (BIO) this year’s global event for biotechnology will take place June 23-26 at the San Diego Convention Center in San Diego California….

Read More
Gilead Sciences GILD NASDAQ:GILD

Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

Kevin Long02 mins

DARA Biosciences Inc (NASDAQ:DARA) on May 15 announced its support for Neuropathy Awareness Week which is being observed during the week of May 12, 2014 and sponsored in the U.S. by The Neuropathy Association (www.neuropathy.org). DARA Biosciences Inc (NASDAQ:DARA) stock performance was -26.61% in last session and finished the day at $1.60. Traded volume was…

Read More